# Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/tolerance-variability-and-pharmacokinetics-of-bevacizumab-biosimilars-in-chinese/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hong Zhang,Qingmei Li,Xiaoxue Zhu,Cuiyun Li,Xiaojiao Li,Chengjiao Liu,Yue Hu,Guiling Chen,Haijing Wei,Jing Wang,Zhenwei Shen,Yanhua Ding |
| Citations | 20 |
| DOI | 10.1007/s00280-018-3645-1 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2883744750 |
| PMID | 30043208 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Xiaojiao Li](https://scholariq.org/researchers/xiaojiao-li/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.